Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution-Reference-Cited by-同舟云学术

Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution

Published:2014-08 Issue:8 Volume:15 Page:
ISSN:1474-760X
Container-title:Genome Biology
language:en
Short-container-title:Genome Biol

Author:

Fisher Rosalie,Horswell Stuart,Rowan Andrew,Salm Maximilian P,de Bruin Elza C,Gulati Sakshi,McGranahan Nicholas,Stares Mark,Gerlinger Marco,Varela Ignacio,Crockford Andrew,Favero Francesco,Quidville Virginie,André Fabrice,Navas Carolina,Grönroos Eva,Nicol David,Hazell Steve,Hrouda David,O’Brien Tim,Matthews Nik,Phillimore Ben,Begum Sharmin,Rabinowitz Adam,Biggs Jennifer,Bates Paul A,McDonald Neil Q,Stamp Gordon,Spencer-Dene Bradley,Hsieh James J,Xu Jianing,Pickering Lisa,Gore Martin,Larkin James,Swanton Charles

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13059-014-0433-z.pdf

Reference65 articles.

1. Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE, Lamiell JM, Haines J, Yuen JW, Collins D, Majoor-Krakauer D, Bonner T, Mathew C, Rubenstein A, Halperin J, McConkie-Rosell A, Green JS, Trofatter JA, Ponder BA, Eierman L, Bowmer MI, Schimke R, Oostra B, Aronin N, Smith DI, Drabkin H, Waziri MH, Hobbs WJ, Martuza RL, Conneally PM, Hsia YE, et al: Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature. 1988, 332: 268-269. 10.1038/332268a0.

2. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993, 260: 1317-1320. 10.1126/science.8493574.

3. Knudson AG: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971, 68: 820-823. 10.1073/pnas.68.4.820.

4. Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Schmidt LS, Toro JR, Karami S, Hung R, Gerard GF, Linehan WM, Merino M, Zbar B, Boffetta P, Brennan P, Rothman N, Chow WH, Waldman FM, Moore LE: Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res. 2008, 14: 4726-4734. 10.1158/1078-0432.CCR-07-4921.

5. Moore LE, Nickerson ML, Brennan P, Toro JR, Jaeger E, Rinsky J, Han SS, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Schmidt LS, Lenz P, Karami S, Linehan WM, Merino M, Chanock S, Boffetta P, Chow WH, Waldman FM, Rothman N: Von Hippel-Lindau (VHL) inactivation in sporadic clear cell renal cancer: associations with germline VHL polymorphisms and etiologic risk factors. PLoS Genet. 2011, 7: e1002312-10.1371/journal.pgen.1002312.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis;Seminars in Diagnostic Pathology;2023-11

2. von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology;Hematology/Oncology Clinics of North America;2023-10

3. Inter- and intra-tumor heterogeneity of genetic and immune profiles in inherited renal cell carcinoma;Cell Reports;2023-07

4. Unraveling the Drivers of Tumorigenesis in the Context of Evolution: Theoretical Models and Bioinformatics Tools;Journal of Molecular Evolution;2023-05-29

5. Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy;The Oncologist;2023-03-14